Large-scale testing (Phase 3)Ended earlyNCT03052725
What this trial is testing
Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic Asthma
Who this might be right for
Eosinophils, Asthma
Teva Branded Pharmaceutical Products R&D, Inc. 391